Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 8, 1996, Pages 1919-1923

  Tohyama, Masaki ^a   Kawakami, Kazuyoshi ^a   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GAMMA INTERFERON; INTERLEUKIN 1; MONOCLONAL ANTIBODY; N(G) METHYLARGININE; NITRIC OXIDE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; CELL STRAIN L 929; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0029846680     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.8.1919     Document Type: Article

References (39)

1. Adams, L. B., S. G. Franzblau, Z. Vavrin, J. B. Hibbs, Jr., and J. L. Krahenbaul. 1991. L-Arginine-dependent macrophage effecter functions inhibit metabolic activity of Mycobacterium leprae. J. Immunol. 147:1642-1646.
2. Alspaugh, J. A., and D. L. Granger. 1991. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59:2291-2296.
3. Cameron, M. L., D. L. Granger, J. B. Weinberg, W. J. Kozumbo, and H. S. Koren. 1990. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am. Rev. Respir. Dis. 142:1313-1319.
4. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
5. Chapman, H. A., Jr., and J. B. Hibbs, Jr. 1978. Modulation of macrophage tumoricidal capability by polyene antibiotics: support for membrane lipid as a regulatory determinant of macrophage function. Proc. Natl. Acad. Sci. USA 75:4349-4353.
6. Chia, J. K. S., and M. Pollack. 1989. Amphotericin B induces tumor necrosis factor production by murine macrophages. J. Infect. Dis. 159:113-116.
7. Denis, M. 1991. Interferon-gamma-treated macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132:150-157.
8. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
9. Domachowske, J. B., and H. L. Malech. 1996. Phagocytes, p. 403. In R. R. Rich, T. A. Fleisher, B. D. Schwartz, W. T. Shearer, and W. Strober (ed.), Clinical immunology: principles and practice. Mosby-Year Book, Inc., St. Louis.
10. Futenma, M., K. Kawakami, and A. Saito. 1995. Production of tumor necrosis factor-α in granulocytopenic mice with pulmonary candidiasis and its modification with granulocyte colony-stimulating factor. Microbiol. Immunol. 39:411-417.
11. Gazinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22:2501-2506.
12. Gelfand, J. A., K. Kimball, J. F. Burke, and C. A. Dinarello. 1988. Amphotericin B treatment of human mononuclcar cells in vitro results in secretion of tumor necrosis factor and interleukin-1. Clin. Res. 36:456. (Abstract.)
13. Granger, D. L., J. B. Hibbs, Jr., J. R. Perfect, and D. T. Durack. 1990. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest. 85:264-267.
14. James, S. L., and J. Glaven. 1989. Macrophage cytotoxity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208-4212.
15. Langermans, J. A. M., M. E. B. van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. van Furth. 1992. IFN-γ-induced L-arginine-dependent toxoplasmatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol. 148:568-574.
16. Liew, F. Y., S. Millott, C. Parkinson, R. M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
17. Little, J. R., E. J. Plut, J. Kotler-Brajtburg, G. Medoff, and G. S. Kobayashi. 1978. Relationship between the antibiotic and immunoadjuvant effects of amphotericin B methyl ester. Immunochemistry 15:219-223.
18. Little, J. R., and J. E. Wolf. 1987. Immunologic effects of amphotericin B. Clin. Immunol. News 8:183-185.
19. Lohr, K. M., and R. Snyderman. 1982. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes. J. Immunol. 129:1594-1599.
20. Matsumoto, T., M. Kaku, N. Furuya, T. Usui, S. Kohno, K. Tomono, K. Tateda, Y. Hirakata, and K. Yamaguchi. 1993. Amphotericin B-induced resistance to Pseudomonas aeruginosa infection in mice. J. Antibiot. 46:777-784.
21. Mehta, R. T., K. Mehta, G. Lopez-Berestein, and R. L. Juliano. 1985. Effects of liposomal amphotericin B on murine macrophages and lymphocytes. Infect. Immun. 47:429-433.
22. Murray, H. W., and Z. A. Cohn. 1980. Macrophages oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. J. Exp. Med. 152:1596-1603.
23. Murray, H. W., and R. F. Teitelbaum. 1992. L-Arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165:513-518.
24. Nathan, C. F. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
25. Nathan, C. F., and J. B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65.
26. Nathan, C. F., S. C. Silverstein, L. H. Brukner, and Z. A. Cohn. 1979. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J. Exp. Med. 149:100-106.
27. Perfect, J. R., D. L. Granger, and D. T. Durack. 1987. Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J. Infect. Dis. 156:316-323.
28. Sarthou, P., D. Primi, and P. A. Cazenave. 1986. B cell triggering properties of a nontoxic derivative of amphotericin B. J. Immunol. 137:2156-2161.
29. Schneeman, M., G. Schoedon, S. Hofer, N. Blaus, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358-1364.
30. Shirley, S. F., and J. R. Little. 1979. Immunopotentiating effects of amphotericin B. I. Enhanced contact sensitivity in mice. J. Immunol. 123:2878-2881.
31. Shirley, S. F., and J. R. Little. 1979. Immunopotentiating effects of amphotericin B. II. Enhanced in vitro proliferative responses of murine lymphocytes. J. Immunol. 123:2883-2889.
32. Stevens, D. A. 1990. Fungal infections in AIDS patients. Br. J. Clin. Pract. 44(Suppl. 1):11-22.
33. Stuehr, D. J., and M. A. Marletta. 1987. Induction of nitrite/nitrate synthesis in murine macrophage by BCG infection, lymphokine, or interferon-γ. J. Immunol. 82:7738-7745.
34. Stuehr, D. J., and C. F. Nathan. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555.
35. Tohyama, M., K. Kawakami, M. Futenma, and A. Saito. 1996. Enhancing effect of oxygen radical scavengers on anticryptococcal activity of murine peritoneal macrophages through production of nitric oxide. Clin. Exp. Immunol. 103:436-441.
36. Tokuda, Y., M. Tsuji, M. Yamazaki, S. Kimura, S. Abe, and H. Yamaguchi. 1993. Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo. Antimicrob. Agents Chemother. 37:2228-2230.
37. Van der Auwera, P. 1988. The immunomodulating effects of antibiotics. Curr. Opin. Infect. Dis. 1:363-374.
38. Vecchiarelli, A., G. Verducci, S. Perito, P. Puccetti, P. Marconi, and F. Bistoni. 1985. Involvement of host macrophages in the immunoadjuvant activity of amphotericin B in a mouse fungal infection model. J. Antibiot. 36:846-855.
39. Wolf, J. E., and S. E. Massof. 1990. In vivo activation of macrophage oxidative burst activity by cytokine and amphotericin B. Infect. Immun. 58: 1296-1300.